Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy (SEX-POInt)
Premature Ovarian Failure
About this trial
This is an interventional other trial for Premature Ovarian Failure focused on measuring premature ovarian insufficiency, sexuality, quality of life
Eligibility Criteria
Inclusion Criteria: positive diagnosis of POI (amenorrhea > 4 months or spaniomenorrhea > 4 months and FSH > 25 IU/L checked twice, more than 4 weeks apart) absence of hormonal treatment, patient's oral consent, affiliated or beneficiary of health insurance Exclusion Criteria: contraindication to hormonal treatment (history of hormone-dependent cancer, history of ischemic arterial stroke), inability of the patient to understand the nature or risks or significance and implications of the clinical investigation, patient under legal protection
Sites / Locations
- CHU BordeauxRecruiting
Arms of the Study
Arm 1
Experimental
Questionnaires
Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and at 6 months after starting hormone replacement therapy.